Buprenorphine
BUP
What is Buprenorphine?
Buprenorphine is a semi-synthetic opioid medication used primarily in the treatment of opioid use disorder (OUD). It works as a partial opioid agonist, meaning it activates opioid receptors enough to prevent withdrawal and reduce cravings but not enough to produce the intense euphoria associated with full opioids like heroin or oxycodone. This unique pharmacology allows buprenorphine to stabilize individuals in recovery and reduce the risk of overdose. Medically, it is prescribed in formulations such as Suboxone® (buprenorphine/naloxone), Subutex® (buprenorphine alone), Bunavail®, and Sublocade® (a long-acting injectable). These come as sublingual tablets, films, or monthly injections.
Illicit or non-prescribed buprenorphine can also appear on the street, typically as diverted prescription tablets or films. Recreational misuse is less common than with other opioids due to buprenorphine’s “ceiling effect,” which limits the level of euphoria it can produce. However, some individuals misuse buprenorphine to self-treat withdrawal, maintain opioid dependence without medical supervision, or combine it with other substances. Because of its role in treatment programs, monitoring appropriate use vs. misuse is often necessary.
Effects:
-
Reduced opioid cravings and withdrawal symptoms
-
Mild euphoria at low doses (less than full opioids)
-
Sedation or drowsiness
-
Constipation
-
Headache and nausea
-
Sweating or flushed skin
-
Reduced respiratory depression compared to full opioids
-
Potential for dependence if misused
-
Precipitated withdrawal if taken too soon after other opioids
-
Impaired coordination or slowed reaction time
Commons Slang Terms:
-
Bup
-
Bupe
-
Subs
-
Strips
-
Oranges (referring to Suboxone’s color)
-
Sabox (mispronunciation of Suboxone)
-
Boxes
-
Sobos
Legal Status:
Buprenorphine is classified as a Schedule III controlled substance, meaning it has legitimate medical use but still carries a risk of misuse and dependence. Because it is widely used in medication-assisted treatment (MAT) programs, many clinical and correctional settings actively screen for buprenorphine to confirm treatment adherence or detect non-prescribed use. Its Schedule III status also means diversion is a recognized concern, prompting many programs to implement regular monitoring.
For point-of-care (POC) rapid toxicology testing programs, buprenorphine is a commonly included analyte, especially in addiction treatment centers, recovery monitoring, corrections, and court-ordered programs. Rapid tests help providers quickly determine whether a patient is taking their prescribed medication as directed or using buprenorphine illicitly. Because false positives can occur with structurally similar opioids, laboratory confirmation is recommended for any presumptive positive result. POC testing ensures timely decision-making, supports treatment compliance, and helps reduce diversion by allowing immediate follow-up when results appear inconsistent with prescribed use.
Screening Options:
LEGEND
GET STARTED
Speak with one of our expert consultants today!
Email Us
info@ntsbiz.com
Phone
1-866-989-9300
Address
550 NW 5th St.
Boca Raton, FL 33486
Monday - Friday
8am - 5pm




